Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4215333
Max Phase: Preclinical
Molecular Formula: C38H31FN2O7S
Molecular Weight: 678.74
Molecule Type: Small molecule
Associated Items:
ID: ALA4215333
Max Phase: Preclinical
Molecular Formula: C38H31FN2O7S
Molecular Weight: 678.74
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: COC(=O)[C@H]1[C@@H](C(=O)OC)C(c2ccccc2)(c2ccccc2)N(c2nc(-c3ccccc3)c(C(=O)c3ccc(F)cc3)s2)[C@H]1C(=O)OC
Standard InChI: InChI=1S/C38H31FN2O7S/c1-46-34(43)28-29(35(44)47-2)38(25-15-9-5-10-16-25,26-17-11-6-12-18-26)41(31(28)36(45)48-3)37-40-30(23-13-7-4-8-14-23)33(49-37)32(42)24-19-21-27(39)22-20-24/h4-22,28-29,31H,1-3H3/t28-,29-,31+/m0/s1
Standard InChI Key: LEYMSAAVPYKTSP-GSBZAIBZSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 678.74 | Molecular Weight (Monoisotopic): 678.1836 | AlogP: 6.06 | #Rotatable Bonds: 9 |
Polar Surface Area: 112.10 | Molecular Species: NEUTRAL | HBA: 10 | HBD: 0 |
#RO5 Violations: 2 | HBA (Lipinski): 9 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: | CX Basic pKa: | CX LogP: 7.78 | CX LogD: 7.78 |
Aromatic Rings: 5 | Heavy Atoms: 49 | QED Weighted: 0.10 | Np Likeness Score: -0.51 |
1. Nural Y, Gemili M, Ulger M, Sari H, De Coen LM, Sahin E.. (2018) Synthesis, antimicrobial activity and acid dissociation constants of methyl 5,5-diphenyl-1-(thiazol-2-yl)pyrrolidine-2-carboxylate derivatives., 28 (5): [PMID:29433925] [10.1016/j.bmcl.2018.01.045] |
Source(1):